Anna Wright Stowell1, Robert J Gatchel, Lynn Wildenstein. 1. Department of Anesthesiology and Pain Management, The Eugene McDermott Center for Pain Management, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9189, USA. anna.stowell@utsouthwestern.edu
Abstract
BACKGROUND: The authors conducted a randomized clinical trial to evaluate the cost-effectiveness of a biopsychosocial intervention with patients who are at high risk (HR) of progressing from acute to chronic TMD-related pain. METHODS: The authors classified 96 patients with acute TMD (less than six months' duration) as HR according to a predictive algorithm and randomized them into an early intervention (EI) or a nonintervention (NI) group. The NI group received a biopsychosocial treatment that included cognitive behavioral skills training and biofeedback. Both groups were followed up for one year. The authors collected TMD cost data throughout the year. RESULTS: The authors found that the EI group spent significantly fewer jaw-related health care dollars, relative to the NI group, from intake to the one-year follow-up. CONCLUSION AND CLINICAL IMPLICATIONS: The reduced jaw-related health care expenditures for patients in the EI group compared with expenditures for patients in the NI group at one year suggest that an early biopsychosocial intervention is a cost-effective measure in dealing with often unnecessarily costly TMD-related pain.
RCT Entities:
BACKGROUND: The authors conducted a randomized clinical trial to evaluate the cost-effectiveness of a biopsychosocial intervention with patients who are at high risk (HR) of progressing from acute to chronic TMD-related pain. METHODS: The authors classified 96 patients with acute TMD (less than six months' duration) as HR according to a predictive algorithm and randomized them into an early intervention (EI) or a nonintervention (NI) group. The NI group received a biopsychosocial treatment that included cognitive behavioral skills training and biofeedback. Both groups were followed up for one year. The authors collected TMD cost data throughout the year. RESULTS: The authors found that the EI group spent significantly fewer jaw-related health care dollars, relative to the NI group, from intake to the one-year follow-up. CONCLUSION AND CLINICAL IMPLICATIONS: The reduced jaw-related health care expenditures for patients in the EI group compared with expenditures for patients in the NI group at one year suggest that an early biopsychosocial intervention is a cost-effective measure in dealing with often unnecessarily costly TMD-related pain.
Authors: Y Wu; S E Cisewski; M C Coombs; M H Brown; F Wei; X She; M J Kern; Y M Gonzalez; L M Gallo; V Colombo; L R Iwasaki; J C Nickel; H Yao Journal: J Dent Res Date: 2019-05-24 Impact factor: 6.116
Authors: Angela Liegey Dougall; Carmen A Jimenez; Robbie A Haggard; Anna W Stowell; Richard R Riggs; Robert J Gatchel Journal: J Orofac Pain Date: 2012
Authors: Gregory J Wright; Jonathan Kuo; Changcheng Shi; Thierry R H Bacro; Elizabeth H Slate; Hai Yao Journal: Ann Biomed Eng Date: 2013-06-15 Impact factor: 3.934
Authors: Ana-Maria Vranceanu; Jeffery R Shaefer; Ashkan Fahandej Saadi; Ellen Slawsby; Jaya Sarin; Matthew Scult; Herbert Benson; John W Denninger Journal: J Musculoskelet Pain Date: 2013-08-24